Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Search results (551)

« Back to Publications

Ensuring participant safety in research studies evaluating digital mental health interventions delivered remotely - insights from the PIPA trial of an online parenting intervention to prevent affective disorders in high-risk adolescents

Madan J. et al, (2026), BMC Medical Research Methodology, 26

Cost-effectiveness of paramedic administered ketamine compared to morphine for the management of acute severe pain from traumatic injury

Khan KA. et al, (2026), Cost Effectiveness and Resource Allocation, 24

Social value of a childhood QALY - Revealed preferences from pharmaceutical funding decisions in Australia 2005–2023

Li JJ. et al, (2026), Social Science and Medicine, 398

Cognitive and Educational Outcomes After Preterm Birth or Low Birth Weight: An Umbrella Review and Meta-Analysis

Hu M. et al, (2026), JAMA Pediatrics, 180, 628 - 638

Factors influencing UK medical students' choice of general practice: a systematic review

Savelkoul C. et al, (2026), British Journal of General Practice the Journal of the Royal College of General Practitioners, 76, e504 - e512

Mapping the benefits and harms of antenatal and newborn screening programmes

Hinton L. et al, (2026), Ssm Qualitative Research in Health, 9

Economic Evaluation of Oral Nirmatrelvir-Ritonavir for COVID-19 in Higher Risk Outpatients

Png ME. et al, (2026), JAMA Network Open, 9

Economic Evaluation of Oral Nirmatrelvir-Ritonavir for COVID-19 in Higher Risk Outpatients

Png ME. et al, (2026), JAMA Network Open, 9, e2612381 - e2612381

Nirmatrelvir–ritonavir versus usual care in at-risk adults with early SARS-CoV-2 infection in the UK, 2022–23: virological and immunological results of an open-label randomised trial (PANORAMIC)

Lowe DM. et al, (2026), Lancet Microbe, 7

Oral Nirmatrelvir-Ritonavir for Covid-19 in Higher-Risk Outpatients

Butler CC. et al, (2026), New England Journal of Medicine, 394, 1583 - 1594

‘What Do People With Long Covid Want From Healthcare Services?’ A Qualitative Exploration From Lived Experience

Rayner C. et al, (2026), Health Expectations, 29

Cost-effectiveness of osteoporotic fracture risk assessment in people with intellectual disabilities: a UK NHS modelling study

Png ME. et al, (2026), BMJ Open, 16

Outcomes in Early Adulthood for Individuals Born Very Preterm and/or with Very Low Birth Weight: Evidence from Multinational Cohorts

Pilvar H. et al, (2026), Journal of Pediatrics Clinical Practice, 19

Perceptions and Experiences of Co-Produced Positive Behaviour Support Training in Community-Based Services and Organisations for Children With Intellectual Disabilities and Behaviours That Challenge: A Qualitative Multiple Case Study Design

Dam R. et al, (2026), Journal of Applied Research in Intellectual Disabilities, 39

Optimising Prescription of Treatment In older patients with Mild hypertension at Increased risk of Serious adverse Events (OPTIMISE2): protocol for a primary care based, open-label, randomised controlled non-inferiority trial

Carr M. et al, (2026), Trials, 27

Load More

1
2
3
4
5
6
7
...
»